Your browser doesn't support javascript.
loading
Ex vivo transdermal delivery of 3H-labelled atovaquone solid drug nanoparticles: a comparison of topical, intradermal injection and microneedle assisted administration.
Morris, Sam; Long, Mark; Savage, Alison; Owen, Andrew; Rannard, Steve; Cauldbeck, Helen.
Afiliação
  • Morris S; Radiomaterials Laboratory, Department of Chemistry, University of Liverpool Crown Street Liverpool L69 7ZD UK helen.cauldbeck@liverpool.ac.uk.
  • Long M; Unilever Research Centre Port Sunlight, Quarry Road East, Bebington Wirral CH63 3JW UK.
  • Savage A; Centre of Excellence in Long-acting Therapeutics (CELT), University of Liverpool Liverpool L7 3NY UK.
  • Owen A; Centre of Excellence in Long-acting Therapeutics (CELT), University of Liverpool Liverpool L7 3NY UK.
  • Rannard S; Department of Pharmacology and Therapeutics, University of Liverpool Liverpool L7 3NY UK.
  • Cauldbeck H; Centre of Excellence in Long-acting Therapeutics (CELT), University of Liverpool Liverpool L7 3NY UK.
Nanoscale Adv ; 5(23): 6400-6404, 2023 Nov 21.
Article em En | MEDLINE | ID: mdl-38024306
ABSTRACT
Inherent barrier properties of the skin impose significant challenges to the transdermal delivery of drugs to systemic circulation. Here, the ex vivo transdermal permeation and deposition of an anti-malarial prophylactic atovaquone solid drug nanoformulation is radiometrically evaluated following application of a solid microneedle format.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Nanoscale Adv Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Nanoscale Adv Ano de publicação: 2023 Tipo de documento: Article